Impact of Left Ventricular Geometry on All-Cause Mortality in Patients Undergoing Hemodialysis: A Longitudinal

Yoshihiro Nakamura1, Shimon Kurasawa1, Toru Kondo2

  • 1Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.

Kidney360
|March 30, 2026
PubMed

Insights

Left ventricular geometry abnormalities, particularly concentric hypertrophy and remodeling, significantly increase mortality risk in hemodialysis patients. Echocardiography can help predict this risk.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Medical Imaging

Background:

  • Left ventricular (LV) geometry classification predicts mortality in hypertension but is inconclusive in hemodialysis patients.
  • LV geometry is categorized into four types based on LV mass index and relative wall thickness.
  • Understanding LV geometry is crucial for risk stratification in chronic kidney disease patients.

Purpose of the Study:

  • To evaluate the association between four categories of LV geometry and all-cause mortality in hemodialysis patients.
  • To determine if LV geometry classification improves mortality risk prediction beyond LV hypertrophy alone.
  • To assess the prevalence of different LV geometry patterns in this population.

Main Methods:

  • Retrospective multicenter cohort study in Japan (October 2006 - December 2021).
  • Included 2228 maintenance hemodialysis patients who underwent echocardiography.
  • Exposure: LV geometry abnormalities (concentric remodeling, eccentric hypertrophy, concentric hypertrophy). Outcome: All-cause death.

Main Results:

  • Nearly 80% of patients had abnormal LV geometry: concentric hypertrophy (30%) and concentric remodeling (27%) were most common.
  • Concentric hypertrophy (aHR 1.32) and concentric remodeling (aHR 1.27) were associated with significantly higher all-cause mortality risk compared to normal geometry.
  • Eccentric hypertrophy showed a similar mortality risk (aHR 1.03) to normal geometry.

Conclusions:

  • Abnormal LV geometry is highly prevalent in hemodialysis patients, with concentric hypertrophy and remodeling posing the greatest mortality risk.
  • Standard LV hypertrophy assessment misses the risk associated with concentric remodeling.
  • Echocardiography-based LV geometry assessment offers valuable risk prediction for hemodialysis patients.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.4K
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
3.2K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.6K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
708
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
1.8K
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.0K